Chemours Announces the U.S. Commercialization of New Low Global Warming Potential Opteon™ Refrigerants

Available for Sale Now, Opteon™ XP40 (R-449A) and Opteon™ XP10 (R-513A) Will Replace Refrigerants SNAP Delisted by EPA in Commercial Refrigeration and Air Conditioning Applications

WILMINGTON, Del.; Aug. 25, 2015 – Chemours announced today that it has commercialized two new low GWP Opteon™ refrigerants in the United States. These new products, Opteon™ XP40 (R-449A) and Opteon™ XP10 (R-513A), recently received SNAP approval by the U.S. EPA.

These are the first in a growing portfolio of low GWP stationary refrigerants that Chemours will introduce to the U.S. market across a variety of applications in the next few years. The commercialization of these refrigerants will help the industry transition away from EPA SNAP delisted products in key applications including commercial refrigeration and air conditioning.

Contractors, supermarkets and other equipment owners can rely on the Opteon™ family of refrigerants to ease the transition away from high GWP refrigerants such as R-404A, 507 and 134a.  Products like Opteon™ XP40 and XP10 will help to meet the industry’s need for more environmentally sustainable, safe and low total cost solutions for refrigeration and air conditioning applications.

Opteon™ XP40 (R-449A) is a nonflammable, low GWP hydrofluorolefin (HFO) blend with a GWP of 1282 (67 percent reduction over R-404A) and is a close performance match to R-404A/507. Lab and field performance tests have even demonstrated an 8-12 percent energy efficiency gain vs. R-404A.  XP40 offers an ideal solution for retrofit and new systems and is the best choice to replace 404A for stationary refrigeration systems.  Opteon™ XP40 has been commercially available in Europe since fall of 2014 and is currently used in hundreds of supermarkets across Europe.

Opteon™ XP10 (R-513A) is a nonflammable, low GWP HFO blend with a GWP of 573 (56 percent reduction over R-134a).  XP10 has an excellent capacity and efficiency match to 134a and is suitable as a 134a replacement in many applications including medium temperature commercial and industrial refrigeration, water chillers, air conditioning and heat pumps.

Both products have been approved by major original equipment manufacturers and are now available for sale in the U.S. today.

The SNAP approval of Opteon™ XP40 and XP10 also coincides with Chemours™ recent announcement that it has doubled capacity of HFO-1234yf from the Zhonghao, China manufacturing facility. As the world’s capacity leader of HFO-1234yf, Chemours™ is uniquely positioned to support our customers growing need for low-GWP blend products in commercial refrigeration, as well as other refrigeration needs such as mobile air conditioning.

“This announcement is another example of the significant shift within the HVACR industry toward the low GWP offerings within our Opteon™ portfolio.” said Diego Boeri, global business director, Chemours Fluorochemicals. “Chemours is committed to continuing to develop and commercialize new high-value offerings based on our breakthrough HFO technology to meet our customers' needs for low GWP refrigerants.”

“Opteon™ low GWP products from Chemours provide critical solutions in response to the regulatory and sustainability demands faced not only in North America but throughout the world”, added Thierry F.J. Vanlancker, president, Chemours Fluoroproducts.  “These solutions will not only meet these new stringent demands by reducing their application’s GWP, but they also improve energy efficiency, further reducing the overall climate change impact.”

As the leading industry supplier of more environmentally sustainable refrigerants, foams and aerosol propellants, Chemours has invested hundreds of millions of dollars to bring to the market new Opteon™ products with no ozone depletion and low global warming potential.  The company and its suppliers have plans to invest hundreds of millions more in the next five years to bring online additional capacity of these more sustainable, high-performance products that serve a wide range of applications.

For more information, visit us at

About The Chemours Company

The Chemours Company helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise, and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™ Viton™, Opteon™ and Nafion™. Chemours has approximately 9,000 employees across 37 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information, please visit or follow Chemours on Twitter at @chemours.

Forward-Looking Statements

This press release contains forward-looking statements, which often may be identified by their use of words like “plans,” “expects,” “will,” “believes,” “intends,” “estimates,” “anticipates” or other words of similar meaning. These forward-looking statements address, among other things, our anticipated future operating and financial performance, business plans and prospects, transformation plans, resolution of environmental liabilities, litigation and other contingencies, plans to increase profitability, our ability to pay or the amount of any dividend, and target leverage that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. The matters discussed in these forward-looking statements also are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements as further described in the “Risk Factors” section of the information statement contained in the registration statement on Form 10 and other filings made by Chemours with the Securities and Exchange Commission. Chemours undertakes no duty to update any forwardlooking statements.


# # #


Andrew Abloeser
Global Marketing Communications Consultant Chemours Fluoroproducts
[email protected]